https://biopharmaperspective.com/2026/10/22/astrazenecas-ultomiris-wins-fda-accelerated-approval-for-iga-nephropathy/ 2026-10-22T03:25:05Z Biopharma Perspective en AstraZeneca’s Ultomiris Wins FDA Accelerated Approval for IgA Nephropathy 2026-10-22T03:25:03Z Blog https://biopharmaperspective.com/2026/10/21/gsks-hibsago-wins-fda-approval-for-chronic-hepatitis-b/ 2026-10-21T02:53:55Z Biopharma Perspective en GSK’s Hibsago Wins FDA Approval for Chronic Hepatitis B 2026-10-21T02:53:54Z Blog